Intravitreal Anti-vascular Endothelial Growth Factor Injection for Retinopathy of Prematurity: A Systematic Review and Meta-Analysis

Intravitreal Anti-vascular Endothelial Growth Factor Injection for Retinopathy of Prematurity: A Systematic Review and Meta-Analysis

BackgroundLaser photocoagulation and/or intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections constitute the current standard treatment for retinopathy of prematurity (ROP). This systematic review and meta-analysis aimed to assess the efficacy and safety of anti-VEGF monotherap...

Full description

Bibliographic Details
Main Authors: Nada O. Taher, Abdullah A. Ghaddaf, Sarah A. Al-Ghamdi, Jumanah J. Homsi, Bandar J. Al-Harbi, Lugean K. Alomari, Hashem S. Almarzouki
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Medicine
Subjects:
retinopathy of prematurity
anti-vascular endothelial growth factor
bevacizumab
ranibizumab
laser photocoagulation
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.884608/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.884608/full

Similar Items